IREN
IREN Limited
There isn't enough reported data to score IREN yet.
MCHB
Mechanics Bank
There isn't enough reported data to score MCHB yet.
IREN Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| N/A | |
| N/A |
IREN's revenue and profitability are currently under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like IREN.
MCHB Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Stable | |
| N/A | |
| N/A |
MCHB's profitability is currently stable. There isn't enough data to rate its revenue. Free cash flow and net leverage aren't meaningful measures for financial services companies like MCHB.
IREN PE Valuation
IREN has no meaningful PE right now: it lost money over the past year.
MCHB PE Valuation
MCHB has no meaningful PE right now: it lost money over the past year.
IREN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect IREN's losses to grow, with revenue growing. However, they disagree widely on these estimates.
MCHB Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Stable | |
| Growth | |
| -- | |
| Limited | |
| Moderate |
Analysts expect MCHB's revenue to grow, with its earnings and profitability holding steady.
IREN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$3.96 | -347% |
| Q2 2026 | -$2.22 | -988% |
| Q1 2026 | $0.51 | +$1.10 |
| Q4 2025 | $1.18 | +$1.62 |
| Q3 2025 | $1.60 | +$1.99 |
| Q2 2025 | $0.25 | +$0.45 |
| Q1 2025 | -$0.59 | -$0.43 |
| Q4 2024 | -$0.44 | -$0.15 |
MCHB has the stronger earnings trend. Trailing diluted EPS is down 347% for IREN versus MCHB down 259%.
MCHB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.07 | — |
| Q3 2024 | -$1.30 | -$0.48 |
| Q2 2024 | -$0.79 | -664% |
| Q1 2024 | -$2.13 | -177% |
| Q4 2023 | -$1.46 | -142% |
| Q3 2023 | -$0.82 | -118% |
| Q2 2023 | $0.14 | -97% |
| Q1 2023 | $2.75 | -46% |
| Q4 2022 | $3.49 | -36% |
MCHB lost $1.30 per share over the past year, a bigger loss than the year before.
IREN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $228M | -5.1% |
| Q2 2026 | $137.2M | -27% |
| Q1 2026 | $144.8M | 0% |
| Q4 2025 | $184.7M | +59% |
| Q3 2025 | $240.3M | +355% |
| Q2 2025 | $187.3M | +230% |
| Q1 2025 | $144.8M | +168% |
| Q4 2024 | $116.1M | +176% |
IREN has the edge over MCHB on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -82% | -50 points |
| Q2 2026 | -452% | -461 points |
| Q1 2026 | -161% | -180 points |
| Q4 2025 | -63% | -79 points |
| Q3 2025 | -32% | +57 points |
| Q2 2025 | 9% | +49 points |
| Q1 2025 | 19% | +8 points |
| Q4 2024 | 15% | +21 points |
IREN's operating margin was −82% last quarter, down 50 points from the same quarter a year ago.
MCHB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $161.5M | -37% |
| Q2 2026 | $201M | +310% |
| Q1 2026 | $200.1M | +341% |
| Q3 2025 | $255.4M | +544% |
| Q2 2025 | $49M | +14% |
| Q1 2025 | $45.4M | +9% |
| Q3 2024 | $39.7M | -20% |
| Q2 2024 | $42.9M | -20% |
MCHB's revenue is growing: $161M last quarter, down 37% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 39% | +21 points |
| Q2 2026 | 39% | +49 points |
| Q1 2026 | 31% | +41 points |
| Q4 2025 | 59% | N/A |
| Q3 2025 | 18% | +42 points |
| Q2 2025 | -9.8% | +8.9 points |
| Q1 2025 | -10% | +15 points |
| Q3 2024 | -24% | -27 points |
MCHB has the edge over IREN on profitability, with a higher operating margin.
IREN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.6B | -$1.6B |
| Q2 2026 | $482.2M | +2895% |
| Q1 2026 | -$873.8M | -$523.1M |
| Q4 2025 | -$468M | -$334M |
| Q3 2025 | -$38M | +$349.4M |
| Q2 2025 | $16.1M | +$179M |
| Q1 2025 | -$350.7M | -$128.7M |
| Q4 2024 | -$134M | -$105.2M |
IREN's free cash flow was −$2.5B over the past year, against −$507M the year before. Free cash flow isn't a meaningful measure for financial services companies like IREN.
MCHB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26.4M | -76% |
| Q2 2026 | $49.6M | +$59.5M |
| Q1 2026 | $8.8M | +$31.3M |
| Q3 2025 | $109.1M | +$126.6M |
| Q2 2025 | -$9.9M | +$12.2M |
| Q1 2025 | -$22.6M | -$8.7M |
| Q3 2024 | -$17.5M | -161% |
| Q2 2024 | -$22M | -213% |
MCHB has the edge over IREN on cash generation, producing positive trailing cash flow while its opponent burns cash.
IREN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +26% | +82.4M shares |
| 1 year | +10% | +36.9M shares |
| 3 years | +511% | +333M shares |
| 5 years | +624% | +344M shares |
| Available history | +2346% | +382M shares |
IREN has 399M diluted shares, up 10% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
MCHB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -- |
| 1 year | +0.3% | +63.9K shares |
| 3 years | -4.4% | -871K shares |
| 5 years | -21% | -4.9M shares |
MCHB has the edge over IREN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | — |
| Q1 2022 | $75M |
IREN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | 157.6x | High |
| Q4 2025 | 22.2x | High |
| Q3 2025 | 4.1x | High |
| Q2 2025 | 2.0x | Moderate |
| Q1 2025 | 3.3x | Elevated |
| Q4 2024 | -4.6x | Net Cash |
| Q3 2024 | -16.7x | Net Cash |
| Q2 2024 | -15.9x | Net Cash |
IREN's net debt is more than 20 years of its operating earnings (EBITDA), up from 3.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like IREN.
MCHB Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.2x | Net Cash |
| Q2 2023 | 128.7x | High |
| Q1 2023 | 22.9x | High |
| Q4 2022 | 12.4x | High |
| Q3 2022 | 14.3x | High |
| Q2 2022 | 12.4x | High |
| Q1 2022 | 2.9x | Moderate |
| Q4 2021 | 0.7x | Very low |
MCHB has more cash than debt. Net leverage isn't a meaningful measure for financial services companies like MCHB.
IREN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.3 | Neutral |
| Stochastic | 8.2 | Oversold |
IREN's weekly RSI is 33 (neutral) and its Stochastic is 8 (oversold).
MCHB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 42.5 | Neutral |
| Stochastic | 16.7 | Oversold |
MCHB's weekly RSI is 42 (neutral) and its Stochastic is 17 (oversold).
IREN PE vs Financial Services Sector
| Metric | IREN | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
IREN has no meaningful PE right now: it lost money over the past year.
MCHB PE vs Financial Services Sector
| Metric | MCHB | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
MCHB has no meaningful PE right now: it lost money over the past year.
IREN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.8 | 35% below |
| 20 week MA | $36.2 | 46% below |
| 50 week MA | $42.8 | 54% below |
| 100 week MA | $32.0 | 39% below |
| 200 week MA | $19.1 | 2.1% above |
IREN has fallen below most of its moving averages, though it's still 2.1% above its 200-week average.
MCHB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $14.7 | 2.2% below |
| 20 week MA | $15.6 | 7.5% below |
| 50 week MA | $15.2 | 5.1% below |
| 100 week MA | $13.6 | 5.7% above |
| 200 week MA | $13.0 | 11% above |
MCHB has the edge over IREN on trend strength, trading above more of its moving averages.
IREN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $24.8 | $17.2 | -31% |
| 2022 | $17.2 | $1.19 | -93% |
| 2023 | $1.19 | $7.15 | +501% |
| 2024 | $7.15 | $10.7 | +50% |
| 2025 | $10.7 | $40.3 | +276% |
| 2026 YTD | $40.3 | $19.5 | -52% |
IREN's yearly returns have swung widely, from +501% in 2023 to −93% in 2022. It's down 52% so far in 2026.
MCHB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $33.9 | $33.5 | -0.9% |
| 2021 | $33.5 | $51.4 | +53% |
| 2022 | $51.4 | $27.0 | -47% |
| 2023 | $27.0 | $10.3 | -62% |
| 2024 | $10.3 | $11.2 | +8.3% |
| 2025 | $11.2 | $14.7 | +31% |
| 2026 YTD | $14.7 | $14.4 | -2% |
MCHB has the edge over IREN on returns for 2026, with the stronger performance.